The global onstep ELISA market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing demand for onstep ELISA kits in various applications such as pharmaceutical and biotechnology companies, diagnostic centers, hospitals and clinics, and others. The increasing number of research studies in the field of immunology has led to an increase in demand for onstep ELISA kits. Moreover, technological advancements have led to an increase in the production capacity of these kits which has also contributed towards the growth of this market.
The global onstep ELISA market by type is segmented into IgG, albumin, TNF alpha, I6 (interleukin-6), fibrinogen (factor I), insulin (hormone), lysozyme (enzyme). The application segment includes pharmaceutical and biotechnology companies; diagnostic centers; hospitals and clinics; others. North America dominates this market with a share of over 40%. Europe follows with a share close to 30%. Asia Pacific accounts for about 25% while Latin America accounts for 10%.
Some Of The Growth Factors Of This Market:
- The One-step ELISA market is driven by the increasing demand for point-of-care diagnostics and the need for rapid, accurate, and cost effective diagnostic tests.
- The One-step ELISA market is also driven by the increasing prevalence of chronic diseases such as diabetes mellitus type 2, cardiovascular diseases, cancer, and autoimmune disorders.
- Increasing government funding for research in this field will also drive the growth of this market.
- Increasing awareness about One-step ELISA among healthcare professionals will also drive the growth of this market.
Industry Growth Insights published a new data on “One-step ELISA Market”. The research report is titled “One-step ELISA Market research by Types (IgG, Albumin, TNF alpha, IL-6, Fibrinogen, Insulin, Lysozyme, Others, ), By Applications (Pharmaceutical and Biotechnology Companies, Diagnostic Centers, Hospitals and Clinics, ), By Players/Companies Abcam, BosterBio, DIALAB, AnaSpec, IDS, PerkinElmer, InBios International, ”.
Scope Of The Report
Report Attributes
Report Details
Report Title
One-step ELISA Market Research Report
By Type
IgG, Albumin, TNF alpha, IL-6, Fibrinogen, Insulin, Lysozyme, Others,
By Application
Pharmaceutical and Biotechnology Companies, Diagnostic Centers, Hospitals and Clinics,
By Companies
Abcam, BosterBio, DIALAB, AnaSpec, IDS, PerkinElmer, InBios International,
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
242
Number of Tables & Figures
170
Customization Available
Yes, the report can be customized as per your need.
Global One-step ELISA Market Report Segments:
The global One-step ELISA market is segmented on the basis of:
Types
IgG, Albumin, TNF alpha, IL-6, Fibrinogen, Insulin, Lysozyme, Others,
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pharmaceutical and Biotechnology Companies, Diagnostic Centers, Hospitals and Clinics,
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abcam
- BosterBio
- DIALAB
- AnaSpec
- IDS
- PerkinElmer
- InBios International
Highlights of The One-step ELISA Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- IgG
- Albumin
- TNF alpha
- IL-6
- Fibrinogen
- Insulin
- Lysozyme
- Others
- By Application:
- Pharmaceutical and Biotechnology Companies
- Diagnostic Centers
- Hospitals and Clinics
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the One-step ELISA Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
One-step ELISA is a type of enzyme-linked immunosorbent assay (ELISA) that uses only one antibody to detect a specific antigen.
Some of the key players operating in the one-step elisa market are Abcam, BosterBio, DIALAB, AnaSpec, IDS, PerkinElmer, InBios International.
The one-step elisa market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. One-step ELISA Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. One-step ELISA Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. One-step ELISA Market - Supply Chain
4.5. Global One-step ELISA Market Forecast
4.5.1. One-step ELISA Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. One-step ELISA Market Size (000 Units) and Y-o-Y Growth
4.5.3. One-step ELISA Market Absolute $ Opportunity
5. Global One-step ELISA Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. One-step ELISA Market Size and Volume Forecast by Type
5.3.1. IgG
5.3.2. Albumin
5.3.3. TNF alpha
5.3.4. IL-6
5.3.5. Fibrinogen
5.3.6. Insulin
5.3.7. Lysozyme
5.3.8. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global One-step ELISA Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. One-step ELISA Market Size and Volume Forecast by Application
6.3.1. Pharmaceutical and Biotechnology Companies
6.3.2. Diagnostic Centers
6.3.3. Hospitals and Clinics
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global One-step ELISA Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. One-step ELISA Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global One-step ELISA Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. One-step ELISA Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global One-step ELISA Demand Share Forecast, 2019-2026
9. North America One-step ELISA Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America One-step ELISA Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America One-step ELISA Market Size and Volume Forecast by Application
9.4.1. Pharmaceutical and Biotechnology Companies
9.4.2. Diagnostic Centers
9.4.3. Hospitals and Clinics
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America One-step ELISA Market Size and Volume Forecast by Type
9.7.1. IgG
9.7.2. Albumin
9.7.3. TNF alpha
9.7.4. IL-6
9.7.5. Fibrinogen
9.7.6. Insulin
9.7.7. Lysozyme
9.7.8. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America One-step ELISA Demand Share Forecast, 2019-2026
10. Latin America One-step ELISA Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America One-step ELISA Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America One-step ELISA Market Size and Volume Forecast by Application
10.4.1. Pharmaceutical and Biotechnology Companies
10.4.2. Diagnostic Centers
10.4.3. Hospitals and Clinics
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America One-step ELISA Market Size and Volume Forecast by Type
10.7.1. IgG
10.7.2. Albumin
10.7.3. TNF alpha
10.7.4. IL-6
10.7.5. Fibrinogen
10.7.6. Insulin
10.7.7. Lysozyme
10.7.8. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America One-step ELISA Demand Share Forecast, 2019-2026
11. Europe One-step ELISA Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe One-step ELISA Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe One-step ELISA Market Size and Volume Forecast by Application
11.4.1. Pharmaceutical and Biotechnology Companies
11.4.2. Diagnostic Centers
11.4.3. Hospitals and Clinics
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe One-step ELISA Market Size and Volume Forecast by Type
11.7.1. IgG
11.7.2. Albumin
11.7.3. TNF alpha
11.7.4. IL-6
11.7.5. Fibrinogen
11.7.6. Insulin
11.7.7 Lysozyme
11.7.8. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe One-step ELISA Demand Share, 2019-2026
12. Asia Pacific One-step ELISA Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific One-step ELISA Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific One-step ELISA Market Size and Volume Forecast by Application
12.4.1. Pharmaceutical and Biotechnology Companies
12.4.2. Diagnostic Centers
12.4.3. Hospitals and Clinics
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific One-step ELISA Market Size and Volume Forecast by Type
12.7.1. IgG
12.7.2. Albumin
12.7.3. TNF alpha
12.7.4. IL-6
12.7.5. Fibrinogen
12.7.6. Insulin
12.7.7. Lysozyme
12.7.8. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific One-step ELISA Demand Share, 2019-2026
13. Middle East & Africa One-step ELISA Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa One-step ELISA Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa One-step ELISA Market Size and Volume Forecast by Application
13.4.1. Pharmaceutical and Biotechnology Companies
13.4.2. Diagnostic Centers
13.4.3. Hospitals and Clinics
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa One-step ELISA Market Size and Volume Forecast by Type
13.7.1. IgG
13.7.2. Albumin
13.7.3. TNF alpha
13.7.4. IL-6
13.7.5. Fibrinogen
13.7.6. Insulin
13.7.7. Lysozyme
13.7.8. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa One-step ELISA Demand Share, 2019-2026
14. Competition Landscape
14.1. Global One-step ELISA Market: Market Share Analysis
14.2. One-step ELISA Distributors and Customers
14.3. One-step ELISA Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Abcam
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. BosterBio
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. DIALAB
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. AnaSpec
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. IDS
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. PerkinElmer
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. InBios International
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
